Adult T-cell leukemia/lymphoma (ATLL) is a highly aggressive peripheral T-cell malignancy that develops after long-term chronic infection with human T-cell lymphotropic virus type-1 (HTLV-1). Despite the recent advances in chemotherapy, allogeneic hematopoietic stem cell transplantation (alloHSCT), and supportive care, the prognosis for patients with ATL is one of the poorest among hematological malignancies; overall survival (OS) at 3 years is only 24
作者：Makoto, Yoshimitsu；Yohann, White；Naomichi, Arima
来源：Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer 2014 年 193卷
